NCT06120751View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

September 30, 2024

Conditions
Tetanus
Interventions
BIOLOGICAL

TTVA

Intramuscular injection, 1 dose of 0.5ml inoculated on Day 0

BIOLOGICAL

TT

Intramuscular injection, 1 dose of 0.5ml inoculated on Day 0

Trial Locations (1)

Unknown

Center for Disease Control and Prevention, Qixingguan District, Bijie City, Bijie

Sponsors
All Listed Sponsors
lead

CanSino Biologics Inc.

INDUSTRY

NCT06120751 - A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over | Biotech Hunter | Biotech Hunter